Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class ASSE: 600332

"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Full Text of the Semi-annual Report for 2026

Aug 22, 2026 · Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A via Shanghai Stock Exchange

Full Text of the Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A

"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a SubsidiaryAug 20
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Receipt of Macao Drug Registration Certificate by SubsidiaryAug 18
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical TrialsAug 11
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Notice on Convening the 1st Extraordinary General Meeting in 2026Aug 8

All Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A news releases